Daniel Teschner at University Medical Center of the Johannes Gutenberg University - Research Interests, Publications & Academic Profile

Daniel Teschner

University Name

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Turkish students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

30%

Internal Medicine

20%

Hematology

50%

Antifungal Therapy

30%

Antimicrobial Stewardship

30%

Fungal Infection

20%

Clinical Risk

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

Article Link

Year:

2023

Chlorhexidine gluconate‐coated gel pad dressings for prevention of central venous catheter‐related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry‐based matched‐pair analysis

Article Link

Year:

2023

Phase 1b safety and pharmacokinetics of intravenous and oral fosmanogepix in patients with acute myeloid leukaemia and neutropenia.

Article Link

Year:

2023

A phase 3 randomized, double-blind, comparator-controlled study to evaluate safety, tolerability and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in allogeneic hematopoietic cell transplant recipients (PNEU-STEM).

Article Link

Year:

2023

Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry.

Article Link

Year:

2023

Performance of T-Track<sup>®</sup> TB, a Novel Dual Marker RT-qPCR-Based Whole-Blood Test for Improved Detection of Active Tuberculosis.

Article Link

Year:

2023

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE) : a multicentre, double-blind, double-dummy, randomised phase 3 trial

Article Link

Year:

2023

Cytomegalovirus infection and rehospitalization rates after allogeneic hematopoietic stem cell and solid organ transplantation: a retrospective cohort study using German claims data

Article Link

Year:

2022

Cytomegalovirus infection and rehospitalization rates after allogeneic hematopoietic stem cell and solid organ transplantation: a retrospective cohort study using German claims data

Article Link

Year:

2022

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.

Article Link

Year:

2022

Collaborators7

Martin Hoenigl

Associate Professor for Translational Mycology

Medical University of Graz

AUSTRIA

Annika Yanina Claßen

GERMANY

Rosanne Sprute

University Hospital Bonn

GERMANY

Enrico Schalk

GERMANY

Werner Heinz

Head of department

GERMANY

Oliver A. Cornely

GERMANY

Sibylle Mellinghoff

University Hospital Bonn

GERMANY

How do Turkish students reach out?

Meet Kite AI